JP2011500764A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500764A5 JP2011500764A5 JP2010530463A JP2010530463A JP2011500764A5 JP 2011500764 A5 JP2011500764 A5 JP 2011500764A5 JP 2010530463 A JP2010530463 A JP 2010530463A JP 2010530463 A JP2010530463 A JP 2010530463A JP 2011500764 A5 JP2011500764 A5 JP 2011500764A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrrolidin
- methoxy
- phenyl
- disorder
- propionamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 208000035475 disorder Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 206010022437 insomnia Diseases 0.000 claims 2
- 230000001193 melatoninergic effect Effects 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- BOQSRQYKGXIQIA-IAXJKZSUSA-N (2s)-2-[1-(3-methoxyphenyl)pyrrolidin-3-yl]butanamide Chemical compound C1C([C@H](CC)C(N)=O)CCN1C1=CC=CC(OC)=C1 BOQSRQYKGXIQIA-IAXJKZSUSA-N 0.000 claims 1
- MMQIUWHHXFUGAP-VUWPPUDQSA-N (2s)-2-fluoro-n-[1-(3-methoxyphenyl)pyrrolidin-3-yl]propanamide Chemical compound COC1=CC=CC(N2CC(CC2)NC(=O)[C@H](C)F)=C1 MMQIUWHHXFUGAP-VUWPPUDQSA-N 0.000 claims 1
- LRSLJDKEWRAQMZ-LLVKDONJSA-N 1-[(3s)-1-(3-methoxyphenyl)pyrrolidin-3-yl]cyclopropane-1-carboxamide Chemical compound COC1=CC=CC(N2C[C@@H](CC2)C2(CC2)C(N)=O)=C1 LRSLJDKEWRAQMZ-LLVKDONJSA-N 0.000 claims 1
- VDQQJMHXZCMNMU-UHFFFAOYSA-N 1-phenylpyrrolidine Chemical class C1CCCN1C1=CC=CC=C1 VDQQJMHXZCMNMU-UHFFFAOYSA-N 0.000 claims 1
- ZYCJOIXTTRTPPP-VIFPVBQESA-N 2,2,2-trifluoro-n-[(3s)-1-(3-methoxyphenyl)pyrrolidin-3-yl]acetamide Chemical compound COC1=CC=CC(N2C[C@H](CC2)NC(=O)C(F)(F)F)=C1 ZYCJOIXTTRTPPP-VIFPVBQESA-N 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000027559 Appetite disease Diseases 0.000 claims 1
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 claims 1
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 1
- 208000001456 Jet Lag Syndrome Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010033664 Panic attack Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 206010039966 Senile dementia Diseases 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 231100001011 cardiovascular lesion Toxicity 0.000 claims 1
- 230000002490 cerebral effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 210000002249 digestive system Anatomy 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- ZOZHFWHRDHNDKD-NSHDSACASA-N ethyl n-[(3s)-1-(3-methoxyphenyl)pyrrolidin-3-yl]carbamate Chemical compound C1[C@@H](NC(=O)OCC)CCN1C1=CC=CC(OC)=C1 ZOZHFWHRDHNDKD-NSHDSACASA-N 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 206010027175 memory impairment Diseases 0.000 claims 1
- CFJDFLKIXFRYLR-JTQLQIEISA-N methyl n-[(3s)-1-(3-methoxyphenyl)pyrrolidin-3-yl]carbamate Chemical compound C1[C@@H](NC(=O)OC)CCN1C1=CC=CC(OC)=C1 CFJDFLKIXFRYLR-JTQLQIEISA-N 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- UJYFWBHTOBRJNK-LBPRGKRZSA-N n-[(3s)-1-(3-methoxyphenyl)pyrrolidin-3-yl]-2,2-dimethylpropanamide Chemical compound COC1=CC=CC(N2C[C@H](CC2)NC(=O)C(C)(C)C)=C1 UJYFWBHTOBRJNK-LBPRGKRZSA-N 0.000 claims 1
- KUOOFEYJCRNFOO-LBPRGKRZSA-N n-[(3s)-1-(3-methoxyphenyl)pyrrolidin-3-yl]-2-methylpropanamide Chemical compound COC1=CC=CC(N2C[C@H](CC2)NC(=O)C(C)C)=C1 KUOOFEYJCRNFOO-LBPRGKRZSA-N 0.000 claims 1
- KNVMZTZPDNRYEJ-ZDUSSCGKSA-N n-[(3s)-1-(3-methoxyphenyl)pyrrolidin-3-yl]-3-methylbutanamide Chemical compound COC1=CC=CC(N2C[C@H](CC2)NC(=O)CC(C)C)=C1 KNVMZTZPDNRYEJ-ZDUSSCGKSA-N 0.000 claims 1
- FQBMUJPNQAMQSX-NSHDSACASA-N n-[(3s)-1-(3-methoxyphenyl)pyrrolidin-3-yl]acetamide Chemical compound COC1=CC=CC(N2C[C@H](CC2)NC(C)=O)=C1 FQBMUJPNQAMQSX-NSHDSACASA-N 0.000 claims 1
- HUNZQHPOZLXJNI-NSHDSACASA-N n-[(3s)-1-(3-methoxyphenyl)pyrrolidin-3-yl]propanamide Chemical compound C1[C@@H](NC(=O)CC)CCN1C1=CC=CC(OC)=C1 HUNZQHPOZLXJNI-NSHDSACASA-N 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 208000019906 panic disease Diseases 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 208000012672 seasonal affective disease Diseases 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200702800A ES2331276B1 (es) | 2007-10-25 | 2007-10-25 | Compuestos de fenilpirrolidina. |
| PCT/EP2008/064390 WO2009053441A1 (en) | 2007-10-25 | 2008-10-23 | Phenylpyrrolidine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011500764A JP2011500764A (ja) | 2011-01-06 |
| JP2011500764A5 true JP2011500764A5 (enExample) | 2011-09-22 |
Family
ID=40291255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010530463A Abandoned JP2011500764A (ja) | 2007-10-25 | 2008-10-23 | フェニルピロリジン化合物 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20120184594A1 (enExample) |
| EP (1) | EP2203422B1 (enExample) |
| JP (1) | JP2011500764A (enExample) |
| KR (1) | KR20100072287A (enExample) |
| CN (1) | CN101878198A (enExample) |
| AR (1) | AR069002A1 (enExample) |
| AT (1) | ATE513809T1 (enExample) |
| AU (1) | AU2008316473A1 (enExample) |
| BR (1) | BRPI0817660A2 (enExample) |
| CA (1) | CA2703458A1 (enExample) |
| CL (1) | CL2008003141A1 (enExample) |
| DK (1) | DK2203422T3 (enExample) |
| ES (2) | ES2331276B1 (enExample) |
| MX (1) | MX2010004469A (enExample) |
| PL (1) | PL2203422T3 (enExample) |
| PT (1) | PT2203422E (enExample) |
| RU (1) | RU2010120845A (enExample) |
| SI (1) | SI2203422T1 (enExample) |
| TW (1) | TW200920353A (enExample) |
| UY (1) | UY31425A1 (enExample) |
| WO (1) | WO2009053441A1 (enExample) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5753709A (en) * | 1995-06-07 | 1998-05-19 | Bristol-Myers Squibb Company | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
| DE60007745T2 (de) * | 1999-06-30 | 2005-03-10 | Bristol-Myers Squibb Co. | Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe |
-
2007
- 2007-10-25 ES ES200702800A patent/ES2331276B1/es not_active Withdrawn - After Issue
-
2008
- 2008-10-23 DK DK08842890.9T patent/DK2203422T3/da active
- 2008-10-23 AT AT08842890T patent/ATE513809T1/de active
- 2008-10-23 AR ARP080104616A patent/AR069002A1/es not_active Application Discontinuation
- 2008-10-23 BR BRPI0817660A patent/BRPI0817660A2/pt not_active IP Right Cessation
- 2008-10-23 SI SI200830368T patent/SI2203422T1/sl unknown
- 2008-10-23 EP EP08842890A patent/EP2203422B1/en not_active Not-in-force
- 2008-10-23 JP JP2010530463A patent/JP2011500764A/ja not_active Abandoned
- 2008-10-23 CN CN2008801131031A patent/CN101878198A/zh active Pending
- 2008-10-23 PL PL08842890T patent/PL2203422T3/pl unknown
- 2008-10-23 WO PCT/EP2008/064390 patent/WO2009053441A1/en not_active Ceased
- 2008-10-23 AU AU2008316473A patent/AU2008316473A1/en not_active Abandoned
- 2008-10-23 MX MX2010004469A patent/MX2010004469A/es active IP Right Grant
- 2008-10-23 US US12/739,708 patent/US20120184594A1/en not_active Abandoned
- 2008-10-23 PT PT08842890T patent/PT2203422E/pt unknown
- 2008-10-23 CA CA2703458A patent/CA2703458A1/en not_active Abandoned
- 2008-10-23 KR KR1020107008900A patent/KR20100072287A/ko not_active Withdrawn
- 2008-10-23 RU RU2010120845/04A patent/RU2010120845A/ru not_active Application Discontinuation
- 2008-10-23 ES ES08842890T patent/ES2368697T3/es active Active
- 2008-10-24 UY UY31425A patent/UY31425A1/es unknown
- 2008-10-24 TW TW097140810A patent/TW200920353A/zh unknown
- 2008-10-24 CL CL2008003141A patent/CL2008003141A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20161672T1 (hr) | Novi kristalni oblik vi agomelatina, postupak priprave i farmaceutski pripravci istog | |
| HRP20170095T1 (hr) | Novi kristalni oblik iii agomelatina, postupak za njegovu pripravu i farmaceutski pripravci istog | |
| TWI327564B (en) | New crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| NZ582056A (en) | Bicyclic heteroaryl compounds for treating conditions related to p2x7 receptor activation | |
| JP2011524850A5 (enExample) | ||
| NZ573565A (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
| JP2004534816A5 (enExample) | ||
| CL2012001501A1 (es) | Co-cristal constituido por agomelatina y un acido organico que presenta un estado solido a temperatura ambiente; procedimientos de preparacion; composicion farmaceutica; y uso en el tratamiento de trastornos del sistema melatoninergico tales como estres, trastornos del sueño y trastornos de ansiedad generalizada, entre otros. | |
| WO2007085556A3 (en) | Use of 4-imidazole derivatives for cns disorders | |
| HRP20201405T1 (hr) | Derivat 5-etil-4-metil-pirazol-3-karboksamida, koji djeluje kao agonist taar-a | |
| NZ617334A (en) | Cyclopropyl amine derivatives | |
| JP2012508275A5 (enExample) | ||
| JP2011529477A5 (enExample) | ||
| JP2009500420A5 (enExample) | ||
| JP2011500763A5 (enExample) | ||
| JP2015521643A5 (enExample) | ||
| JP2010529130A5 (enExample) | ||
| JP2014518552A5 (enExample) | ||
| RU2010120847A (ru) | Соединения индолина, фармацевтическая композиция на их основе и способ лечения или профилактики мелатонинергических заболеваний | |
| EA200801488A1 (ru) | Замещенные фенетиламины, обладающие серотонинергической и/или норэпинефринергической активностью | |
| RU2011107443A (ru) | Индаценовые соединения, фармацевтическая композиция и лекарственное средство на их основе, способ их получения и способ лечения или профилактики состояний, связанных с нарушением функционирования систем, регулируемых мелатонином, с их помощью | |
| JP2011500764A5 (enExample) | ||
| JP2005527477A5 (enExample) | ||
| JP2007529492A5 (enExample) | ||
| PH12014501293A1 (en) | Phenylpyrrole derivative |